Spot and Futures Linkage Sparks Controversy, VELVET Token Faces Significant Selling Pressure Following Short-Term Surge
BlockBeats News, June 11, according to EmberCN monitoring, the DEX project Velvet Capital's token VELVET recently experienced abnormal price fluctuations, soaring from around $0.09 to $0.9 in a short period of time, with a cumulative increase of 10x.
During the rapid price increase, the project's associated address transferred approximately 22 million VELVET to Bitget and an exchange within the past 3 days, totaling about $19.8 million, interpreted by the market as potential concentrated selling pressure.
In addition, the liquidity provider DWF Labs also moved around 6.68 million VELVET to the aforementioned exchanges in the past month, worth approximately $6 million.
The on-chain fund flow coincided with the rapid price surge, sparking community discussion on the "spot price ramp-up + contract harvesting" model.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Just about three months after listing, two SK Hynix leveraged ETFs are set to be delisted in the United States.
Tradr ETFs announced that its two leveraged products linked to SK Hynix ADRs will be liquidated and delisted around November 12, with one being long and the other short. Despite only being listed for a few months, their combined scale has shrunk to about $1.3 million, down more than 60% from their peak. SK Hynix's Seoul stock price has fallen 56% from its high, similar products in the industry are generally under pressure, and South Korea has also further tightened regulations on leveraged products.
WTI Price Forecast: Slides further below $100.50; bullish potential seems intact
A $5 billion single-product emerges? JPMorgan maintains a "Neutral" rating on Amgen (AMGN.US): A good drug doesn't necessarily mean a good buying opportunity.
Amgen's Imdelltra has maintained data with an HR of 0.42, nearly doubling survival time. Morgan Stanley estimates that it will become a single product with annual sales of around 5 billions USD. However, they maintain a Neutral rating and a target price of 350 USD.
Crypto prices
More
